Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
5,432,030
-
Shares change
-
-178,130
-
Total reported value, excl. options
-
$23,304,557
-
Value change
-
-$881,069
-
Put/Call ratio
-
58%
-
Number of buys
-
12
-
Number of sells
-
18
-
Price
-
$4.29
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2021
As of 31 Dec 2021 Eton Pharmaceuticals, Inc. - Common Stock (ETON) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,432,030 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., Roumell Asset Management, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Westside Investment Management, Inc., MARSHALL WACE, LLP, PARADIGM CAPITAL MANAGEMENT INC/NY, and STATE STREET CORP.
This table shows 45 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.